Affärssegment Mesa Laboratories, Inc.
Aktier
MLAB
US59064R1095
Medicinsk utrustning, förnödenheter & distribution
|
Realtidsuppskattning
Cboe BZX
17.48.09 2026-09-11
|
5-dagars förändring | Förändring 1 jan. | ||
| 123,36 USD | +2,03 % |
|
−3,46 % | +57,15 % |
| 08-10 | Mesa Laboratories, Inc., Q1 2027 Earnings Call, Aug 10, 2026 | |
| 08-10 | Mesa Laboratories rapporterar resultat för första kvartalet 2026 | CI |
Försäljning 2026 per affärssegment
Försäljning 2026 efter Geografi
Historisk fördelning av intäkter per affärssegment
Gross Profit: Fördelning efter verksamhetssegment
Historik över geografisk fördelning av omsättning
| Skatteperiod: Mars | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
Medical Equipment | ||||||||||
Sterilization and Disinfection Control | 59,04 mn | 64,61 mn | 75,12 mn | 93,42 mn | 102 mn | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
Gross Profit | 43,72 mn | 46,52 mn | 53,3 mn | 64,66 mn | 71,71 mn | |||||
D&A | - | - | - | 1,92 mn | 2,3 mn | |||||
| - | - | - | - | 102 mn | ||||||
Medical Testing, Analyzing, and Diagnostic Equipment | ||||||||||
Calibration Solutions | 46,87 mn | 44,81 mn | 47,76 mn | 51,75 mn | 53,55 mn | |||||
Gross Profit | 24,99 mn | 24,39 mn | 27,55 mn | 30,64 mn | 31,98 mn | |||||
D&A | - | - | - | 837 tn | 448 tn | |||||
Instruments | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
Gross Profit | - | - | - | - | - | |||||
D&A | - | - | - | - | - | |||||
| - | - | - | - | 53,55 mn | ||||||
Life Sciences Tools and Services | ||||||||||
Biopharmaceutical Development | 45,58 mn | 47,36 mn | 40,71 mn | 48,73 mn | 48,63 mn | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
Gross Profit | 28,6 mn | 30,34 mn | 25,4 mn | 29,91 mn | 28,55 mn | |||||
D&A | - | - | - | 1,6 mn | 1,82 mn | |||||
| - | - | - | - | 45,39 mn | ||||||
Clinical Genomics | 32,84 mn | 62,3 mn | 52,59 mn | 47,08 mn | 45,39 mn | |||||
Gross Profit | 11,94 mn | 32,48 mn | 27,08 mn | 25,67 mn | 26,03 mn | |||||
D&A | - | - | - | 1,44 mn | 1,34 mn | |||||
| - | - | - | - | 48,63 mn | ||||||
Plastic Packaging | ||||||||||
Cold Chain Packaging | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
Gross Profit | - | - | - | - | - | |||||
Measuring, Analyzing, and Controlling Instruments | ||||||||||
Continuous Monitoring | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
Gross Profit | - | - | - | - | - | |||||
D&A | - | - | - | - | - | |||||
Corporate and Other | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
Gross Profit | −165 tn | −40 tn | −77 tn | −10 tn | - | |||||
D&A | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - |
| Skatteperiod: Mars | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
United States | 99,07 mn | 117 mn | 106 mn | 117 mn | 117 mn | |||||
Total Assets | 36,48 mn | 34,73 mn | 32,23 mn | 29,2 mn | 29,89 mn | |||||
Other | - | 76 mn | 84,86 mn | 99,05 mn | 112 mn | |||||
Total Assets | - | - | 2,48 mn | 1,17 mn | 1,21 mn | |||||
| - | - | - | - | 117 mn | ||||||
China | - | 25,8 mn | 24,93 mn | 25,31 mn | 20,45 mn | |||||
Total Assets | - | - | 7,6 mn | 6,71 mn | 5,96 mn | |||||
Total Assets | - | - | - | 11,63 mn | 10,86 mn | |||||
Foreign | 85,27 mn | - | - | - | - | |||||
Total Assets | 3,98 mn | 3,79 mn | - | - | - | |||||
| - | - | - | - | 20,45 mn | ||||||
| - | - | - | - | 112 mn |
- Börsen
- Aktier
- MLAB Aktie
- Finanser Mesa Laboratories, Inc.
- Affärssegment
Välj din utgåva
All finansiell information anpassad till den nationella nivån
